- Home
- LXFR vs HRTX Comparison
LXFR vs HRTX Comparison
Compare LXFR & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXFR
- HRTX
- Stock Information
- Founded
- LXFR 1898
- HRTX 1983
- Country
- LXFR United States
- HRTX United States
- Employees
- LXFR N/A
- HRTX N/A
- Industry
- LXFR Major Chemicals
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- LXFR Industrials
- HRTX Health Care
- Exchange
- LXFR Nasdaq
- HRTX Nasdaq
- Market Cap
- LXFR 335.4M
- HRTX 276.1M
- IPO Year
- LXFR 2012
- HRTX 1987
- Fundamental
- Price
- LXFR $13.42
- HRTX $1.35
- Analyst Decision
- LXFR
- HRTX Strong Buy
- Analyst Count
- LXFR 0
- HRTX 2
- Target Price
- LXFR N/A
- HRTX $4.50
- AVG Volume (30 Days)
- LXFR 135.6K
- HRTX 2.6M
- Earning Date
- LXFR 10-28-2025
- HRTX 08-08-2025
- Dividend Yield
- LXFR 3.87%
- HRTX N/A
- EPS Growth
- LXFR N/A
- HRTX N/A
- EPS
- LXFR 0.90
- HRTX N/A
- Revenue
- LXFR $403,800,000.00
- HRTX $149,694,000.00
- Revenue This Year
- LXFR $3.12
- HRTX $10.62
- Revenue Next Year
- LXFR $3.31
- HRTX $12.99
- P/E Ratio
- LXFR $13.74
- HRTX N/A
- Revenue Growth
- LXFR 5.60
- HRTX 9.78
- 52 Week Low
- LXFR $9.41
- HRTX $1.04
- 52 Week High
- LXFR $15.64
- HRTX $2.68
- Technical
- Relative Strength Index (RSI)
- LXFR 64.00
- HRTX 36.48
- Support Level
- LXFR $12.32
- HRTX $1.33
- Resistance Level
- LXFR $13.86
- HRTX $1.43
- Average True Range (ATR)
- LXFR 0.45
- HRTX 0.07
- MACD
- LXFR 0.11
- HRTX 0.02
- Stochastic Oscillator
- LXFR 78.85
- HRTX 45.45
About LXFR Luxfer Holdings PLC
Luxfer Holdings PLC is a manufacturer industrial company innovating niche applications in materials engineering. It focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean, and energy-efficient world. Luxfer's high-performance materials, components, and high-pressure gas containment devices are used in defense, first response and healthcare, transportation, and general industrial applications. It focuses on product lines related to magnesium alloys, zirconium chemicals, and carbon composites. Its segments are Elektron, Gas Cylinders, and Graphic Arts. It generates the majority of its revenue from Elektron and as well as Gas Cylinders.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.